André DeLÉAN

3.2k total citations · 1 hit paper
15 papers, 2.9k citations indexed

About

André DeLÉAN is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Animal Science and Zoology. According to data from OpenAlex, André DeLÉAN has authored 15 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Animal Science and Zoology. Recurrent topics in André DeLÉAN's work include Receptor Mechanisms and Signaling (6 papers), Heart Failure Treatment and Management (4 papers) and Pharmacological Effects and Assays (4 papers). André DeLÉAN is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Heart Failure Treatment and Management (4 papers) and Pharmacological Effects and Assays (4 papers). André DeLÉAN collaborates with scholars based in Canada and United States. André DeLÉAN's co-authors include Peter J. Munson, David Rodbard, Robert J. Lefkowitz, Arthur A. Hancock, Jeffrey M. Stadel, Sylvain Meloche, P. Larose, Patrick du Souich, Hui Xin Ong and P D'Amour and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Biochemical Journal.

In The Last Decade

André DeLÉAN

14 papers receiving 2.8k citations

Hit Papers

Simultaneous analysis of families of sigmoidal curves: ap... 1978 2026 1994 2010 1978 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André DeLÉAN Canada 11 1.5k 960 453 330 328 15 2.9k
André De Léan Canada 27 1.5k 1.0× 736 0.8× 360 0.8× 359 1.1× 741 2.3× 64 2.5k
L E Limbird United States 36 3.0k 2.0× 1.8k 1.9× 579 1.3× 275 0.8× 454 1.4× 60 4.4k
Peter W. Abel United States 33 2.7k 1.8× 1.4k 1.4× 1.0k 2.3× 319 1.0× 424 1.3× 118 4.4k
F. Dray France 35 1.4k 0.9× 1.2k 1.2× 589 1.3× 590 1.8× 232 0.7× 185 4.2k
G. Alan Robison United States 31 2.2k 1.4× 1.0k 1.0× 1.2k 2.6× 649 2.0× 470 1.4× 57 4.6k
G. Bertaccini Italy 33 1.5k 1.0× 1.6k 1.6× 683 1.5× 253 0.8× 96 0.3× 250 3.9k
J. D. M. Albano United Kingdom 11 1.0k 0.7× 548 0.6× 432 1.0× 468 1.4× 110 0.3× 28 2.3k
Shang‐Zhong Xu China 35 1.8k 1.2× 861 0.9× 415 0.9× 168 0.5× 343 1.0× 98 4.0k
J. Adolfo García‐Sáinz Mexico 37 3.7k 2.4× 1.6k 1.6× 1.2k 2.5× 595 1.8× 416 1.3× 239 5.4k
Paul R. Murdock United Kingdom 30 1.8k 1.2× 1.2k 1.2× 1.1k 2.3× 286 0.9× 367 1.1× 44 4.6k

Countries citing papers authored by André DeLÉAN

Since Specialization
Citations

This map shows the geographic impact of André DeLÉAN's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André DeLÉAN with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André DeLÉAN more than expected).

Fields of papers citing papers by André DeLÉAN

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André DeLÉAN. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André DeLÉAN. The network helps show where André DeLÉAN may publish in the future.

Co-authorship network of co-authors of André DeLÉAN

This figure shows the co-authorship network connecting the top 25 collaborators of André DeLÉAN. A scholar is included among the top collaborators of André DeLÉAN based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André DeLÉAN. André DeLÉAN is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Piñeyro, Graciela, Mounia Azzi, André DeLÉAN, Peter W. Schiller, & Michel Bouvier. (2004). Reciprocal Regulation of Agonist and Inverse Agonist Signaling Efficacy upon Short-Term Treatment of the Human δ-Opioid Receptor with an Inverse Agonist. Molecular Pharmacology. 67(1). 336–348. 19 indexed citations
2.
Labrecque, Jean, et al.. (2002). Allotopic antagonism of the non-peptide atrial natriuretic peptide (ANP) antagonist HS-142-1 on natriuretic peptide receptor NPR-A. Biochemical Journal. 362(1). 231–231. 9 indexed citations
3.
Labrecque, Jean, et al.. (2002). Allotopic antagonism of the non-peptide atrial natriuretic peptide (ANP) antagonist HS-142-1 on natriuretic peptide receptor NPR-A. Biochemical Journal. 362(2). 231–237. 6 indexed citations
4.
D'Amour, P, et al.. (1992). The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration.. The Journal of Clinical Endocrinology & Metabolism. 74(3). 525–532. 68 indexed citations
5.
DeLÉAN, André, et al.. (1990). Synthesis and biological activity profiles of atrial natriuretic factor (ANF) analogs. International journal of peptide & protein research. 36(2). 156–160.
6.
Quirion, Rémi, et al.. (1988). Characterisation, distribution, and plasticity of atrial natriuretic factor binding sites in brain. Canadian Journal of Physiology and Pharmacology. 66(3). 280–287. 18 indexed citations
7.
Schiller, Peter W., Thi M.‐D. Nguyen, J.-G. J. Godin, et al.. (1987). Superactive analogs of the atrial natriuretic peptide (ANP). Biochemical and Biophysical Research Communications. 143(2). 499–505. 9 indexed citations
8.
Schiller, Peter W., et al.. (1986). Synthesis and activity profiles of atrial natriuretic peptide (ANP) analogs with reduced ring size. Biochemical and Biophysical Research Communications. 138(2). 880–886. 23 indexed citations
9.
Larose, P., Sylvain Meloche, Patrick du Souich, André DeLÉAN, & Hui Xin Ong. (1985). Radioimmunoassay of atrial natriuretic factor: Human plasma levels. Biochemical and Biophysical Research Communications. 130(2). 553–558. 99 indexed citations
10.
Goltzman, David, et al.. (1984). Discordant Disappearance of Bioactive and Immunoreactive Parathyroid Hormone after Parathyroidectomy*. The Journal of Clinical Endocrinology & Metabolism. 58(1). 70–75. 45 indexed citations
11.
Bürgisser, Ernst, Robert J. Lefkowitz, & André DeLÉAN. (1981). Alternative Explanation for the Apparent "Two-Step" Binding Kinetics of High-Affinity Racemic Antagonist Radioligands. Molecular Pharmacology. 19(3). 509–512. 28 indexed citations
12.
Stadel, Jeffrey M., André DeLÉAN, & Robert J. Lefkowitz. (1980). A high affinity agonist . beta-adrenergic receptor complex is an intermediate for catecholamine stimulation of adenylate cyclase in turkey and frog erythrocyte membranes.. Journal of Biological Chemistry. 255(4). 1436–1441. 129 indexed citations
13.
Hancock, Arthur A., André DeLÉAN, & Robert J. Lefkowitz. (1979). Quantitative Resolution of Beta-Adrenergic Receptor Subtypes by Selective Ligand Binding: Application of a Computerized Model Fitting Technique. Molecular Pharmacology. 16(1). 1–9. 181 indexed citations
14.
15.
DeLÉAN, André, Peter J. Munson, & David Rodbard. (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.. American Journal of Physiology-Endocrinology and Metabolism. 235(2). E97–E97. 2264 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026